Air pollutants increase gene expression of the vasoconstrictor endothelin-1 in the lungs

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1689, Issue 1, 2004, Pages 75-82

  Thomson, Errol ^a,b   Goegan, Patrick ^a   Kumarathasan, Prem ^a   Vincent, Renaud ^a,b  

^a HEALTH CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Air pollution; Cardiovascular disease; Endothelin 1 (ET 1); Endothelin converting enzyme 1 (ECE 1); Ozone; Particulate matter

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN RECEPTOR; MESSENGER RNA; OZONE; PREPROENDOTHELIN 3; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

AIR POLLUTANT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXPOSURE; GENE EXPRESSION; GENE EXPRESSION REGULATION; INHALATION; LUNG VASOCONSTRICTION; MALE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RAT; URBAN AREA;

ADMINISTRATION, INHALATION; AIR POLLUTANTS; ANIMALS; ENDOTHELIN-1; GENE EXPRESSION REGULATION; HUMANS; LUNG; MALE; OZONE; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASOCONSTRICTION;

EID: 2442673772     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2004.02.001     Document Type: Article

References (49)

1. Burnett R.T., Dales R., Krewski D., Vincent R., Dann T., Brook J.R. Associations between ambient particulate sulfate and admissions to Ontario hospitals for cardiac and respiratory diseases. Am. J. Epidemiol. 142:1995;15-22
2. Goldberg M.S., Burnett R.T., Bailar J.C. III, Tamblyn R., Ernst P., Flegel K., Brook J., Bonvalot Y., Singh R., Valois M.F., Vincent R. Identification of persons with cardiorespiratory conditions who are at risk of dying from the acute effects of ambient air particles. Environ. Health Perspect. 109(Suppl. 4):2001;487-494
3. Goldberg M.S., Burnett R.T., Valois M.F., Flegel K., Bailar J.C. III, Brook J., Vincent R., Radon K. Associations between ambient air pollution and daily mortality among persons with congestive heart failure. Environ. Res. 91:2003;8-20
4. Burnett R.T., Brook J., Dann T., Delocla C., Philips O., Cakmak S., Vincent R., Goldberg M.S., Krewski D. Association between particulate- and gas-phase components of urban air pollution and daily mortality in eight Canadian cities. Inhal. Toxicol. 12(Suppl 4):2000;15-39
5. Goldberg M.S., Burnett R.T., Brook J., Bailar J.C. III, Valois M.F., Vincent R. Associations between daily cause-specific mortality and concentrations of ground-level ozone in Montreal, Quebec. Am. J. Epidemiol. 154:2001;817-826
6. Magari S.R., Schwartz J., Williams P.L., Hauser R., Smith T.J., Christiani D.C. The association of particulate air metal concentrations with heart rate variability. Environ. Health Perspect. 110:2002;875-880
7. Bouthillier L., Vincent R., Goegan P., Adamson I.Y., Bjarnason S., Stewart M., Guenette J., Potvin M., Kumarathasan P. Acute effects of inhaled urban particles and ozone: lung morphology, macrophage activity, and plasma endothelin-1. Am. J. Pathol. 153:1998;1873-1884
8. Vincent R., Kumarathasan P., Goegan P., Bjarnason S.G., Guenette J., Berube D., Adamson I.Y., Desjardins S., Burnett R.T., Miller F.J., Battistini B. Inhalation toxicology of urban ambient particulate matter: acute cardiovascular effects in rats. Res. Rep.-Health Eff. Inst. 2001;5-54
9. Calderon-Garciduenas L., Mora-Tiscareno A., Fordham L.A., Valencia-Salazar G., Chung C.J., Rodriguez-Alcaraz A., Paredes R., Variakojis D., Villarreal-Calderon A., Flores-Camacho L., Antunez-Solis A., Henriquez-Roldan C., Hazucha M.J. Respiratory damage in children exposed to urban pollution. Pediatr. Pulmonol. 36:2003;148-161
10. Brook R.D., Brook J.R., Urch B., Vincent R., Rajagopalan S., Silverman F. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation. 105:2002;1534-1536
11. Kang Y.J., Li Y., Zhou Z., Roberts A.M., Cai L., Myers S.R., Wang L., Schuschke D.A. Elevation of serum endothelins and cardiotoxicity induced by particulate matter (PM(2.5)) in rats with acute myocardial infarction. Cardiovasc. Toxicol. 2:2002;253-262
12. Suwa T., Hogg J.C., Quinlan K.B., Ohgami A., Vincent R., Van Eeden S.F. Particulate air pollution induces progression of atherosclerosis. J. Am. Coll. Cardiol. 39:2002;935-942
13. Haynes W.G., Ferro C.E., Webb D.J. Physiologic role of endothelin in maintenance of vascular tone in humans. J. Cardiovasc. Pharmacol. 26(Suppl. 3):1995;S183-S185
14. Dupuis J., Stewart D.J., Cernacek P., Gosselin G. Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation. 94:1996;1578-1584
15. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2863-2867
16. Turner A.J., Murphy L.J. Molecular pharmacology of endothelin converting enzymes. Biochem. Pharmacol. 51:1996;91-102
17. Bremnes T., Paasche J.D., Mehlum A., Sandberg C., Bremnes B., Attramadal H. Regulation and intracellular trafficking pathways of the endothelin receptors. J. Biol. Chem. 275:2000;17596-17604
18. Alonso D., Radomski M.W. The nitric oxide-endothelin-1 connection. Heart Fail. Rev. 8:2003;107-115
19. Anggard E., Galton S., Rae G., Thomas R., McLoughlin L., de Nucci G., Vane J.R. The fate of radioiodinated endothelin-1 and endothelin-3 in the rat. J. Cardiovasc. Pharmacol. 13(Suppl. 5):1989;S46-S49
20. Hemsen A., Pernow J., Lundberg J.M. Regional extraction of endothelins and conversion of big endothelin to endothelin-1 in the pig. Acta Physiol. Scand. 141:1991;325-334
21. Yamaguchi T., Murata Y., Fujiyoshi Y., Doi T. Regulated interaction of endothelin B receptor with caveolin-1. Eur. J. Biochem. 270:2003;1816-1827
22. Luscher T.F., Barton M. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation. 102:2000;2434-2440
23. Kobayashi T., Miyauchi T., Sakai S., Maeda S., Yamaguchi I., Goto K., Sugishita Y. Down-regulation of ET(B) receptor, but not ET(A) receptor, in congestive lung secondary to heart failure. Are marked increases in circulating endothelin-1 partly attributable to decreases in lung ET(B) receptor-mediated clearance of endothelin-1? Life Sci. 62:1998;185-193
24. Lepailleur-Enouf D., Egidy G., Philippe M., Louedec L., Henry J., Mulder P., Michel J. Pulmonary endothelinergic system in experimental congestive heart failure. Cardiovasc. Res. 49:2001;330-339
25. Ulrich M.M., Alink G.M., Kumarathasan P., Vincent R., Boere A.J., Cassee F.R. Health effects and time course of particulate matter on the cardiopulmonary system in rats with lung inflammation. J. Toxicol. Environ. Health, Part A. 65:2002;1571-1595
26. Challah M., Nadaud S., Philippe M., Battle T., Soubrier F., Corman B., Michel J.B. Circulating and cellular markers of endothelial dysfunction with aging in rats. Am. J. Physiol. 273:1997;H1941-H1948
27. Orfanos S.E., Armaganidis A., Glynos C., Psevdi E., Kaltsas P., Sarafidou P., Catravas J.D., Dafni U.G., Langleben D., Roussos C. Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury. Circulation. 102:2000;2011-2018
28. Vincent R., Goegan P., Johnson G., Brook J.R., Kumarathasan P., Bouthillier L., Burnett R.T. Regulation of promoter-CAT stress genes in HepG2 cells by suspensions of particles from ambient air. Fundam. Appl. Toxicol. 39:1997;18-32
29. Vincent R., Bjarnason S.G., Adamson I.Y., Hedgecock C., Kumarathasan P., Guenette J., Potvin M., Goegan P., Bouthillier L. Acute pulmonary toxicity of urban particulate matter and ozone. Am. J. Pathol. 151:1997;1563-1570
30. Wang X., Douglas S.A., Feuerstein G.Z., Ohlstein E.H. Temporal expression of ECE-1, ET-1, ET-3, ETA, and ETB receptor mRNAs after balloon angioplasty in the rat. J. Cardiovasc. Pharmacol. 26(Suppl. 3):1995;S22-S25
31. Kodavanti U.P., Jackson M.C., Ledbetter A.D., Richards J.R., Gardner S.Y., Watkinson W.P., Campen M.J., Costa D.L. Lung injury from intratracheal and inhalation exposures to residual oil fly ash in a rat model of monocrotaline-induced pulmonary hypertension. J. Toxicol. Environ. Health, Part A. 57:1999;543-563
32. Schlesinger R.B. Deposition and clearance of inhaled particles. McClellan R.O., Henderson R.F. Concepts in Inhalation Toxicology. 1989;163-192 Hemisphere Publishing, New York
33. Tellez-Rojo M.M., Romieu I., Ruiz-Velasco S., Lezana M.A., Hernandez-Avila M.M. Daily respiratory mortality and PM10 pollution in Mexico City: importance of considering place of death. Eur. Respir. J. 16:2000;391-396
34. Miller F.J., Overton J.H., Gerrity T.R., Graham R.C. Interspecies dosimetry of reactive gases. Dungworth D., Kimmerle G., Lewkoski J., McClellan R., Stober W. Inhalation Toxicology: The Design and Interpretation of Inhalation Studies and Their Use in Risk Assessment. 1988;139-155 Springer-Verlag, New York
35. Valdenaire O., Rohrbacher E., Mattei M.G. Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J. Biol. Chem. 270:1995;29794-29798
36. Paul M., Zintz M., Bocker W., Dyer M. Characterization and functional analysis of the rat endothelin-1 promoter. Hypertension. 25:1995;683-693
37. Inoue A., Yanagisawa M., Takuwa Y., Mitsui Y., Kobayashi M., Masaki T. The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression. J. Biol. Chem. 264:1989;14954-14959
38. Quehenberger P., Bierhaus A., Fasching P., Muellner C., Klevesath M., Hong M., Stier G., Sattler M., Schleicher E., Speiser W., Nawroth P.P. Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes. 49:2000;1561-1570
39. Tsutamoto T., Wada A., Maeda Y., Adachi T., Kinoshita M. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure. J. Am. Coll. Cardiol. 23:1994;1427-1433
40. Shiba R., Sakurai T., Yamada G., Morimoto H., Saito A., Masaki T., Goto K. Cloning and expression of rat preproendothelin-3 cDNA. Biochem. Biophys. Res. Commun. 186:1992;588-594
41. Gerbes A.L., Moller S., Gulberg V., Henriksen J.H. Endothelin -1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function. Hepatology. 21:1995;735-739
42. Wright J.L., Tai H., Dai J., Churg A. Cigarette smoke induces rapid changes in gene expression in pulmonary arteries. Lab. Invest. 82:2002;1391-1398
43. Vincent R., Adamson I.Y. Cellular kinetics in the lungs of aging Fischer 344 rats after acute exposure to ozone. Am. J. Pathol. 146:1995;1008-1016
44. Zhao Q., Simpson L.G., Driscoll K.E., Leikauf G.D. Chemokine regulation of ozone-induced neutrophil and monocyte inflammation. Am. J. Physiol. 274:1998;L39-L46
45. Galatius-Jensen S., Wroblewski H., Emmeluth C., Bie P., Haunso S., Kastrup J. Plasma endothelin in congestive heart failure: a predictor of cardiac death? J. Card. Fail. 2:1996;71-76
46. Omland T., Lie R.T., Aakvaag A., Aarsland T., Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation. 89:1994;1573-1579
47. Ihling C., Szombathy T., Bohrmann B., Brockhaus M., Schaefer H.E., Loeffler B.M. Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation. 104:2001;864-869
48. Hatch G.E., Slade R., Harris L.P., McDonnel W.F., Devlin R.B., Koren H.S., Costa D.L., McKee J. Ozone dose and effect in humans and rats. A comparison using oxygen-18 labeling and bronchoalveolar lavage. Am. J. Respir. Crit. Care Med. 150:1994;676-683
49. Moss O.R., Gross E.A., James R.A., Janszen D.B., Ross P.W., Roberts K.C., Howard A.M., Harkema J.R., Calderon-Garciduenas L., Morgan K.T. Respiratory tract toxicity in rats exposed to Mexico City air. Res. Rep.-Health Eff. Inst. 2001;1-24